US Stock MarketDetailed Quotes

ETON Eton Pharmaceutical

Watchlist

3.600
-0.060-1.64%

Close May 23 16:00 ET

92.49MMarket Cap120.00P/E (TTM)

Eton Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

50.19%7.97M

48.90%31.64M

-13.94%7.31M

118.33%7.03M

63.05%12M

143.75%5.3M

-2.66%21.25M

39.47%8.5M

315.35%3.22M

139.91%7.36M

Operating revenue

50.19%7.97M

48.90%31.64M

-13.94%7.31M

118.33%7.03M

63.05%12M

143.75%5.3M

-2.66%21.25M

39.47%8.5M

315.35%3.22M

139.91%7.36M

Cost of revenue

51.12%2.96M

52.62%10.58M

72.26%3.68M

118.57%2.63M

-15.66%2.32M

130.62%1.96M

145.24%6.93M

474.73%2.14M

83.64%1.2M

1,477.59%2.75M

Gross profit

49.64%5.01M

47.09%21.06M

-42.92%3.63M

118.19%4.4M

109.89%9.68M

152.15%3.35M

-24.66%14.32M

11.17%6.36M

1,567.77%2.02M

59.45%4.61M

Operating expense

-1.24%5.81M

-1.44%22.25M

6.13%5.62M

0.77%4.95M

-2.59%5.8M

-8.33%5.88M

10.14%22.58M

20.22%5.3M

-17.68%4.91M

14.09%5.95M

Selling and administrative expenses

-3.54%5.16M

1.88%18.93M

5.10%4.58M

4.01%4.34M

-11.19%4.67M

11.45%5.35M

30.26%18.58M

16.85%4.35M

26.72%4.17M

63.04%5.26M

-General and administrative expense

-3.54%5.16M

1.88%18.93M

5.10%4.58M

4.01%4.34M

-11.19%4.67M

11.45%5.35M

30.26%18.58M

16.85%4.35M

26.72%4.17M

63.04%5.26M

Research and development costs

21.68%651K

-16.87%3.32M

10.91%1.05M

-17.34%615K

63.04%1.13M

-66.93%535K

-35.91%4M

38.62%944K

-72.22%744K

-65.33%690K

Operating profit

68.43%-800K

85.57%-1.19M

-287.66%-1.99M

81.07%-548K

389.78%3.88M

50.19%-2.53M

-452.51%-8.26M

-19.18%1.06M

50.49%-2.9M

42.37%-1.34M

Net non-operating interest income expense

91.27%-11K

166.10%503K

622.67%784K

79.33%-31K

43.12%-124K

48.15%-126K

24.35%-761K

45.45%-150K

39.27%-150K

8.02%-218K

Non-operating interest expense

-91.27%11K

----

-79.33%31K

-43.12%124K

-48.15%126K

----

-39.27%150K

-8.02%218K

Total other finance cost

----

-166.10%-503K

----

-24.35%761K

----

Other net income (expense)

800K

Special income (charges)

----

--0

----

--0

----

-Gain on sale of property,plant,equipment

----

--0

----

--0

----

Other non- operating income (expenses)

----

--800K

----

Income before tax

69.51%-811K

92.36%-689K

-320.29%-2.01M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

50.03%-3.05M

22.72%-1.56M

Income tax

247K

Net income

69.51%-811K

89.62%-936K

-347.37%-2.26M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

50.03%-3.05M

22.72%-1.56M

Net income continuous Operations

69.51%-811K

89.62%-936K

-347.37%-2.26M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

50.03%-3.05M

22.72%-1.56M

Minority interest income

Net income attributable to the parent company

69.51%-811K

89.62%-936K

-347.37%-2.26M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

50.03%-3.05M

22.72%-1.56M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

69.51%-811K

89.62%-936K

-347.37%-2.26M

80.99%-579K

392.62%4.56M

50.09%-2.66M

-361.43%-9.02M

-12.22%912K

50.03%-3.05M

22.72%-1.56M

Basic earnings per share

70.00%-0.03

88.89%-0.04

-325.00%-0.09

83.33%-0.02

400.00%0.18

52.38%-0.1

-350.00%-0.36

0.00%0.04

50.00%-0.12

25.00%-0.06

Diluted earnings per share

70.00%-0.03

88.89%-0.04

-325.00%-0.09

83.33%-0.02

400.00%0.18

52.38%-0.1

-350.00%-0.36

0.00%0.04

50.00%-0.12

25.00%-0.06

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	50.19%7.97M	48.90%31.64M	-13.94%7.31M	118.33%7.03M	63.05%12M	143.75%5.3M	-2.66%21.25M	39.47%8.5M	315.35%3.22M	139.91%7.36M
Operating revenue	50.19%7.97M	48.90%31.64M	-13.94%7.31M	118.33%7.03M	63.05%12M	143.75%5.3M	-2.66%21.25M	39.47%8.5M	315.35%3.22M	139.91%7.36M
Cost of revenue	51.12%2.96M	52.62%10.58M	72.26%3.68M	118.57%2.63M	-15.66%2.32M	130.62%1.96M	145.24%6.93M	474.73%2.14M	83.64%1.2M	1,477.59%2.75M
Gross profit	49.64%5.01M	47.09%21.06M	-42.92%3.63M	118.19%4.4M	109.89%9.68M	152.15%3.35M	-24.66%14.32M	11.17%6.36M	1,567.77%2.02M	59.45%4.61M
Operating expense	-1.24%5.81M	-1.44%22.25M	6.13%5.62M	0.77%4.95M	-2.59%5.8M	-8.33%5.88M	10.14%22.58M	20.22%5.3M	-17.68%4.91M	14.09%5.95M
Selling and administrative expenses	-3.54%5.16M	1.88%18.93M	5.10%4.58M	4.01%4.34M	-11.19%4.67M	11.45%5.35M	30.26%18.58M	16.85%4.35M	26.72%4.17M	63.04%5.26M
-General and administrative expense	-3.54%5.16M	1.88%18.93M	5.10%4.58M	4.01%4.34M	-11.19%4.67M	11.45%5.35M	30.26%18.58M	16.85%4.35M	26.72%4.17M	63.04%5.26M
Research and development costs	21.68%651K	-16.87%3.32M	10.91%1.05M	-17.34%615K	63.04%1.13M	-66.93%535K	-35.91%4M	38.62%944K	-72.22%744K	-65.33%690K
Operating profit	68.43%-800K	85.57%-1.19M	-287.66%-1.99M	81.07%-548K	389.78%3.88M	50.19%-2.53M	-452.51%-8.26M	-19.18%1.06M	50.49%-2.9M	42.37%-1.34M
Net non-operating interest income expense	91.27%-11K	166.10%503K	622.67%784K	79.33%-31K	43.12%-124K	48.15%-126K	24.35%-761K	45.45%-150K	39.27%-150K	8.02%-218K
Non-operating interest expense	-91.27%11K	----	----	-79.33%31K	-43.12%124K	-48.15%126K	----	----	-39.27%150K	-8.02%218K
Total other finance cost	----	-166.10%-503K	----	----	----	----	-24.35%761K	----	----	----
Other net income (expense)					800K
Special income (charges)	----	--0	----	----	----	----	--0	----	----	----
-Gain on sale of property,plant,equipment	----	--0	----	----	----	----	--0	----	----	----
Other non- operating income (expenses)	----	----	----	----	--800K	----	----	----	----	----
Income before tax	69.51%-811K	92.36%-689K	-320.29%-2.01M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K	50.03%-3.05M	22.72%-1.56M
Income tax	0	247K	247K	0	0	0	0	0	0	0
Net income	69.51%-811K	89.62%-936K	-347.37%-2.26M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K	50.03%-3.05M	22.72%-1.56M
Net income continuous Operations	69.51%-811K	89.62%-936K	-347.37%-2.26M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K	50.03%-3.05M	22.72%-1.56M
Minority interest income
Net income attributable to the parent company	69.51%-811K	89.62%-936K	-347.37%-2.26M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K	50.03%-3.05M	22.72%-1.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	69.51%-811K	89.62%-936K	-347.37%-2.26M	80.99%-579K	392.62%4.56M	50.09%-2.66M	-361.43%-9.02M	-12.22%912K	50.03%-3.05M	22.72%-1.56M
Basic earnings per share	70.00%-0.03	88.89%-0.04	-325.00%-0.09	83.33%-0.02	400.00%0.18	52.38%-0.1	-350.00%-0.36	0.00%0.04	50.00%-0.12	25.00%-0.06
Diluted earnings per share	70.00%-0.03	88.89%-0.04	-325.00%-0.09	83.33%-0.02	400.00%0.18	52.38%-0.1	-350.00%-0.36	0.00%0.04	50.00%-0.12	25.00%-0.06
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall